The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis
and pregnancy morbidity in association with the persistent presence of autoantibodies …

Objectives This review aims to identify biological markers of the risk of recurrence of
thrombotic and/or obstetric events in patients with antiphospholipid syndrome (APS) …

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …

The antiphospholipid syndrome (APS) is characterised by thrombotic or obstetric symptoms
associated with persistent antiphospholipid antibodies (aPL). Despite an increasing …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
presence of antiphospholipid antibodies (aPL) in subjects presenting with thrombosis and/or …

This issue of Seminars in Thrombosis & Hemostasis is devoted to antiphospholipid (aPL)
antibodies and the antiphospholipid syndrome (APS). aPL antibodies are well-recognized …

Objective This study aimed to assess prospectively the role of anti-ß2-glycoprotein I domain I
antibody (aß2GPI-DI) and the Global Antiphospholipid Syndrome Score (GAPSS) in …

Background: Obstetric morbidity (OM) is a common feature of antiphospholipid syndrome
(OAPS). Women having OAPS-only and women with OM related to antiphospholipid …

The description of antiphospholipid syndrome (APS) is vascular thrombosis and/or
pregnancy morbidity occurring in persons with antiphospholipid antibodies (aPL). However …

The present clinical and laboratory classification criteria for antiphospholipid syndrome
(APS) were established in Sydney, Australia, in 2006. In this review, we focus on the …